Al Lodola brings to HEATHICS its extensive experience in all aspects of the nonclinical drug development including strategy development and review regarding all the principal treatment routes. Specific domains of expertise are the following:

• Due diligence review
• Nonclinical strategy review and development
• Nonclinical issues review and resolution
• CRO identification, study design, placement, and management and reporting
• Nonclinical document including CTD review and preparation
• Preparation and participation to regulatory meetings